Precision BioSciences promotes Neil Leatherbury to SVP CMC; co-founder Derek Jantz moves to advisory role

PRECISION BIOSCIENCES INC

Neil Leatherbury promoted to SVP, Head of CMC, reporting to CEO Michael Amoroso.
Co-founder Derek Jantz steps down as CSO, becomes Co-Founder and Chief Science Advisor.
Co-founder Jeff Smith continues as Chief Research Officer, now leads joint steering committees with Lilly and Novartis.
CMC promotion follows FDA Type C feedback on azer-cel manufacturing processes.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Derek Jantz

Co-Founder and Chief Science Advisor

DTIL · PRECISION BIOSCIENCES INC

Filed: February 24, 2023, 6:59 PM ET

On February 22, 2023, Derek Jantz, Ph.D. notified Precision BioSciences, Inc. (the “Company” or “Precision”) of his intentions to gradually step away from his current day-to-day responsibilities at Precision to pursue other personal and professional interests while continuing to support the Company’s external relationships, including with existing and potential business development partners.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Derek Jantz changed role as Co-Founder and Chief Science Advisor at PRECISION BIOSCIENCES INC.

Action: stepped down
Role: Co-Founder and Chief Science Advisor

Exact text from the filing

On February 22, 2023, Derek Jantz, Ph.D. notified Precision BioSciences, Inc. (the “Company” or “Precision”) of his intentions to gradually step away from his current day-to-day responsibilities at Precision to pursue other personal and professional interests while continuing to support the Company’s external relationships, including with existing and potential business development partners.

View on SEC.gov

PRECISION BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0000950170-23-004240

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.